Synthesis of New Peptide Derivatives of Galanthamine Designed for Prevention and Treatment of Alzheimer’s Disease

E-ISSN： 1875-5305|22|10|913-922

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.22, Iss.10, 2015-01, pp. : 913-922

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-neuroinflammatory agents for the treatment of Alzheimer’s disease

By Zhou Wei Hu Wenhui

Future Medicinal Chemistry, Vol. 5, Iss. 13, 2013-09 ,pp. : 1559-1571

Future Science

Access to resources Recommend Favorite

Oxidative imbalance in alzheimer’s disease

By Zhu Xiongwei Lee Hyoung-gon Casadesus Gemma Avila Jesus Drew Kelly Perry George Smith Mark

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 205-217

Humana Press, Inc

Access to resources Recommend Favorite

Molecular basis of Alzheimer’s disease

By Grigorenko A. Rogaev E.

Molecular Biology, Vol. 41, Iss. 2, 2007-04 ,pp. : 294-307

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Methionine oxidation: Implications for the mechanism of toxicity of the -amyloid peptide from Alzheimers disease

By Giuseppe D. Ciccotosto

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 413-417

Springer Publishing Company

Access to resources Recommend Favorite

Cryogenic solid state NMR studies of fibrils of the Alzheimer’s disease amyloid-β peptide: perspectives for DNP

By Lopez del Amo Juan-Miguel Schneider Dennis Loquet Antoine Lange Adam Reif Bernd

Journal of Biomolecular NMR, Vol. 56, Iss. 4, 2013-08 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite